The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamidebased chemotherapy in premenopausal highrisk patients with breast cancer
Bioportfolio,
The PAM50-based (Prosigna) risk of recurrence (ROR) score and intrinsic subtypes are prognostic for women with high-risk breast…